News

The Prostate Cancer Charity comments on new draft guidance issued by NICE today (30 September) that it is not recommending the use of cabazitaxel as a treatment for men with advanced prostate cancer.

The Prostate Cancer Charity comments on new research, published in Cancer Epidemiology, Biomarkers and Prevention, which has uncovered five genetic variants believed to play a key role in the progression and a man's chances of dying from the disease.

Scientists funded by The Prostate Cancer Charity and the Medical Research Council have taken a step forward in understanding how prostate cancer grows, with the discovery of several genes that play an unexpected role in controlling the development of the disease, according to new research published today in Oncogene.

Abstract sumbission now closed

Scientists and researchers are invited to submit an abstract to profile their work at the Charity's National Research Conference 'From laboratory to life: Progress in prostate cancer'.

Scientists funded by The Prostate Cancer Charity and the Medical Research Council have taken a step forward in understanding how prostate cancer  grows, with the discovery of several genes that play an unexpected role in controlling the development of the disease, according to new research published today (Monday) in Oncogene.

The Prostate Cancer Charity comments on the latest Office For National Statistics Cancer Registrations report, which indicates that the diagnosis rate of prostate cancer continues to rise.